Camarda Financial Advisors’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-30,731
Closed -$4.17M 94
2022
Q4
$4.17M Buy
+30,731
New +$4.07M 4.21% 3
2022
Q3
Sell
-26,629
Closed -$3.42M 88
2022
Q2
$3.42M Sell
26,629
-29,385
-52% -$3.85M 3.38% 9
2022
Q1
$7.67M Buy
+56,014
New +$7.42M 3.66% 6
2021
Q4
Sell
-77,036
Closed -$9.81M 115
2021
Q3
$9.81M Buy
77,036
+71,799
+1,371% +$9.49M 6.61% 8
2021
Q2
$660K Sell
5,237
-54,656
-91% -$6.7M 0.41% 60
2021
Q1
$6.99M Buy
59,893
+201
+0.3% +$23.2K 5% 2
2020
Q4
$6.77M Sell
59,692
-1,150
-2% -$126K 5.7% 3
2020
Q3
$6.42M Buy
60,842
+2,102
+4% +$221K 7.79% 5
2020
Q2
$5.88M Buy
+58,740
New +$5.8M 8.22% 5
2019
Q2
Sell
-186
Closed -$17K 590
2019
Q1
$17K Buy
+186
New +$16.8K 0.03% 153

Other funds holding XLV

Camarda Financial Advisors's XLV Position: Q1 2023 in Review

Camarda Financial Advisors sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q1 2023, closing a stake of 30,731 shares — an estimated $4.17M sold.

Camarda Financial Advisors first reported a position in XLV in Q1 2019 and held it in 10 quarters. The position peaked at $9.81M in Q3 2021. 1,509 funds tracked by Wall St. Rank hold XLV as of Q1 2023.

  • Camarda Financial Advisors reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q1 2023 after selling out during the quarter.
  • Camarda Financial Advisors sold 30,731 State Street Health Care Select Sector SPDR ETF shares in Q1 2023, an estimated $4.17M.
  • Camarda Financial Advisors first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2019 and held it in 10 quarters.
  • Camarda Financial Advisors's State Street Health Care Select Sector SPDR ETF position peaked at $9.81M in Q3 2021.
  • 1,509 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2023.

Based on Camarda Financial Advisors's 13F filing for Q1 2023, filed 11 May 2023.